E. Tsianos

发表

Pyoderma gangrenosum: successful treatment with intralesional injections of corticosteroids

G. Dalekos, C. Tzermias, J. Hatzis, 1995 .

Thymosin alpha‐1 with peginterferon alfa‐2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?

A. Mangia, S. Pol, M. Milella, 2012, Journal of viral hepatitis.

Treatment and non-treatment related ocular manifestations in patients with chronic hepatitis B or C.

K. Katsanos, I. Asproudis, V. Theopistos, 2013, European review for medical and pharmacological sciences.

Pathogenetic mechanisms of hypomagnesemia in alcoholic patients.

M. Elisaf, K. Siamopoulos, E. Tsianos, 1995, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

Increased incidence of anti‐cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti‐phospholipid syndrome

P. Voulgari, A. Drosos, D. Boumba, 2000, European journal of gastroenterology & hepatology.

Azathioprine/6-mercaptopurine toxicity: The role of the TPMT gene

E. Tsianos, Kh. K.H. Katsanos, K. Katsanos, 2008 .

Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markers.

M. Elisaf, M. Pappas, E. Tsianos, 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Acid-base and electrolyte abnormalities in alcoholic patients.

M. Elisaf, K. Siamopoulos, E. Tsianos, 1994, Mineral and electrolyte metabolism.

Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: results of a 3-year prospective donor study (1995-1997).

D. Boumba, G. Dalekos, C. Liaskos, 2003, European journal of internal medicine.

Interferon‐α therapy in HBeAg‐negative chronic hepatitis B: a long‐term prospective study from north‐western Greece

K. Katsanos, E. Tsianos, P. Karayiannis, 2006, Alimentary pharmacology & therapeutics.

Increased prevalence of markers of GBV-C/HGV infection in a selected cohort of haemodialysis patients negative for other blood-borne viruses.

M. Elisaf, D. Boumba, G. Dalekos, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Absence of HCV viraemia in anti-HCV-negative haemodialysis patients.

M. Elisaf, K. Siamopoulos, D. Boumba, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit

M. Elisaf, K. Bourantas, E. Tsianos, 1998, Transfusion.

Prevalence of viral markers among refugees from southern Albania: increased incidence of infection with hepatitis A, B and D viruses.

G. Dalekos, E. Tsianos, E. Zervou, 1995, European journal of gastroenterology & hepatology.

A case of nonarteritic anterior ischemic optic neuropathy of a male with family history of the disease after receiving sildenafil

K. Katsanos, I. Asproudis, E. Tsianos, 2011, Clinical ophthalmology.

Non-TPMT determinants of azathioprine toxicity in inflammatory bowel disease

K. Katsanos, E. Tsianos, 2010 .

Suppressors of cytokine signaling as tumor repressors. Silencing of SOCS3 facilitates tumor formation and growth in lung and liver.

N. Baltayiannis, E. Tsianos, G. Baltayiannis, 2008, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

High frequency of antibodies to Hantaan virus and hepatitis C virus in chronic haemodialysis patients Coincidence or cross‐reaction?

M. Elisaf, G. Dalekos, K. Siamopoulos, 1993, Journal of Internal Medicine.